TR200101470T2 - Farmasötik bileşim terkipleri. - Google Patents
Farmasötik bileşim terkipleri.Info
- Publication number
- TR200101470T2 TR200101470T2 TR2001/01470T TR200101470T TR200101470T2 TR 200101470 T2 TR200101470 T2 TR 200101470T2 TR 2001/01470 T TR2001/01470 T TR 2001/01470T TR 200101470 T TR200101470 T TR 200101470T TR 200101470 T2 TR200101470 T2 TR 200101470T2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical composition
- composition compositions
- pharmaceutically acceptable
- acceptable salt
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut bulus, aktif maddeler olarak karvedilol veya bunun farmasötik açidan kabul görür bir tuzunu ve hidroklorotiyazit veya bunun farmasötik açidan kabul görür bir tuzunu bunlarin yanisira farmasötik açidan yaygin katki maddelerini içeren, hipertansiyon, gögüs anjini, kalp yetmezligi gibi kalp ve dolasim sistemi bozukluklarinin ve bunlarla ilgili hastaliklarin tedavisine yönelik bir farmasötik bilesim terkibi ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98122489 | 1998-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101470T2 true TR200101470T2 (tr) | 2001-11-21 |
Family
ID=8233041
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00981T TR200200981T2 (tr) | 1998-11-27 | 1999-11-20 | Farmasötik bileşim terkipleri |
TR2002/00982T TR200200982T2 (tr) | 1998-11-27 | 1999-11-20 | Farmasötik bileşim terkipleri. |
TR2001/01470T TR200101470T2 (tr) | 1998-11-27 | 1999-11-20 | Farmasötik bileşim terkipleri. |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00981T TR200200981T2 (tr) | 1998-11-27 | 1999-11-20 | Farmasötik bileşim terkipleri |
TR2002/00982T TR200200982T2 (tr) | 1998-11-27 | 1999-11-20 | Farmasötik bileşim terkipleri. |
Country Status (22)
Country | Link |
---|---|
US (3) | US6403579B1 (tr) |
EP (1) | EP1131072B1 (tr) |
JP (2) | JP2002531395A (tr) |
KR (1) | KR100421347B1 (tr) |
CN (1) | CN1184971C (tr) |
AR (1) | AR020287A1 (tr) |
AT (1) | ATE238056T1 (tr) |
AU (1) | AU765977B2 (tr) |
BR (1) | BR9915610A (tr) |
CA (1) | CA2352361C (tr) |
CO (1) | CO5011053A1 (tr) |
DE (1) | DE69907252T2 (tr) |
DK (1) | DK1131072T3 (tr) |
ES (1) | ES2195638T3 (tr) |
MY (1) | MY121831A (tr) |
PE (1) | PE20001302A1 (tr) |
PT (1) | PT1131072E (tr) |
TR (3) | TR200200981T2 (tr) |
TW (1) | TWI228414B (tr) |
UY (1) | UY25821A1 (tr) |
WO (1) | WO2000032174A2 (tr) |
ZA (1) | ZA200104280B (tr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
AU2001297631A1 (en) * | 2000-10-24 | 2002-09-04 | Smithkline Beecham Corporation | Novel formulations of carvedilol |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
IN191028B (tr) * | 2001-05-17 | 2003-09-13 | Sun Pharmaceutical Ind Ltd | |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
AU2003231283A1 (en) * | 2002-04-30 | 2003-11-17 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
BR0312102A (pt) | 2002-06-27 | 2007-05-29 | Sb Pharmco Inc | sais de fosfato de carvedilol e/ou seus solvatos, composições correspondentes, e/ou métodos de tratamento |
WO2004002472A1 (en) | 2002-06-27 | 2004-01-08 | Sb Pharmco Puerto Rico Inc. | Carvedilol hydrobromide |
AU2003275953A1 (en) | 2002-11-08 | 2004-06-07 | Egalet A/S | Controlled release carvedilol compositions |
DE602004031096D1 (de) | 2003-03-26 | 2011-03-03 | Egalet As | Morphin-system mit kontrollierter freisetzung |
EP1615888A1 (en) * | 2003-04-21 | 2006-01-18 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
WO2005030201A1 (fr) * | 2003-09-26 | 2005-04-07 | Shuyi Zhang | Preparation a liberation prolongee contenant de l'hydrochlorothiazide et du carvedilol/atenolol |
EP1686967A4 (en) * | 2003-11-25 | 2012-08-08 | Smithkline Beecham Cork Ltd | CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES |
WO2005051322A2 (en) * | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts |
JP2007512372A (ja) | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | カルベジロール塩、対応する組成物、送達および/または治療方法 |
PL380065A1 (pl) * | 2003-12-02 | 2006-12-11 | Nicox S.A. | Nitrooksypochodne karwedilolu i inne beta blokery jako leki przeciwko nadciśnieniu |
WO2006089674A2 (en) * | 2005-02-25 | 2006-08-31 | F.Hoffmann-La Roche Ag | Tablets with improved drug substance dispersibility |
WO2007144175A2 (en) * | 2006-06-16 | 2007-12-21 | Lek Pharmaceuticals D.D. | Pharmaceutical composition comprising hydrochlorothiazide and telmisartan |
GB0612540D0 (en) * | 2006-06-23 | 2006-08-02 | Novartis Ag | Galenical formulations of organic compounds |
WO2008114276A1 (en) * | 2007-03-16 | 2008-09-25 | Lupin Limited | Novel oral controlled release composition of carvedilol |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
WO2010149169A2 (en) | 2009-06-24 | 2010-12-29 | Egalet A/S | Controlled release formulations |
CA2792647A1 (en) * | 2010-03-10 | 2011-09-15 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
FR2671970B1 (fr) * | 1991-01-30 | 1995-06-23 | Wellcome Found | Comprimes dispersables dans l'eau. |
DE69222006T2 (de) * | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
-
1999
- 1999-11-19 PE PE1999001171A patent/PE20001302A1/es not_active Application Discontinuation
- 1999-11-20 JP JP2000584870A patent/JP2002531395A/ja active Pending
- 1999-11-20 WO PCT/EP1999/008972 patent/WO2000032174A2/en active IP Right Grant
- 1999-11-20 TR TR2002/00981T patent/TR200200981T2/tr unknown
- 1999-11-20 DE DE69907252T patent/DE69907252T2/de not_active Expired - Lifetime
- 1999-11-20 AT AT99957320T patent/ATE238056T1/de active IP Right Maintenance
- 1999-11-20 CA CA002352361A patent/CA2352361C/en not_active Expired - Lifetime
- 1999-11-20 CN CNB998137561A patent/CN1184971C/zh not_active Expired - Lifetime
- 1999-11-20 BR BR9915610-5A patent/BR9915610A/pt not_active Application Discontinuation
- 1999-11-20 TR TR2002/00982T patent/TR200200982T2/tr unknown
- 1999-11-20 KR KR10-2001-7006570A patent/KR100421347B1/ko active IP Right Grant
- 1999-11-20 ES ES99957320T patent/ES2195638T3/es not_active Expired - Lifetime
- 1999-11-20 EP EP99957320A patent/EP1131072B1/en not_active Expired - Lifetime
- 1999-11-20 AU AU15065/00A patent/AU765977B2/en not_active Expired
- 1999-11-20 PT PT99957320T patent/PT1131072E/pt unknown
- 1999-11-20 TR TR2001/01470T patent/TR200101470T2/tr unknown
- 1999-11-20 DK DK99957320T patent/DK1131072T3/da active
- 1999-11-23 US US09/447,872 patent/US6403579B1/en not_active Expired - Lifetime
- 1999-11-24 AR ARP990105974A patent/AR020287A1/es unknown
- 1999-11-25 CO CO99074400A patent/CO5011053A1/es unknown
- 1999-11-25 MY MYPI99005155A patent/MY121831A/en unknown
- 1999-11-26 UY UY25821A patent/UY25821A1/es unknown
-
2000
- 2000-02-23 TW TW089103144A patent/TWI228414B/zh not_active IP Right Cessation
-
2001
- 2001-05-24 ZA ZA200104280A patent/ZA200104280B/xx unknown
- 2001-09-05 US US09/946,205 patent/US20020052367A1/en not_active Abandoned
-
2003
- 2003-10-24 US US10/693,243 patent/US20040087578A1/en not_active Abandoned
-
2006
- 2006-10-19 JP JP2006284476A patent/JP2007077160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK1131072T3 (da) | 2003-08-11 |
EP1131072B1 (en) | 2003-04-23 |
ZA200104280B (en) | 2002-08-26 |
CN1328460A (zh) | 2001-12-26 |
ATE238056T1 (de) | 2003-05-15 |
WO2000032174A3 (en) | 2000-11-16 |
MY121831A (en) | 2006-02-28 |
CA2352361C (en) | 2007-01-02 |
PE20001302A1 (es) | 2000-11-30 |
ES2195638T3 (es) | 2003-12-01 |
PT1131072E (pt) | 2003-08-29 |
CN1184971C (zh) | 2005-01-19 |
US6403579B1 (en) | 2002-06-11 |
CO5011053A1 (es) | 2001-02-28 |
BR9915610A (pt) | 2001-08-14 |
WO2000032174A2 (en) | 2000-06-08 |
KR20010080578A (ko) | 2001-08-22 |
CA2352361A1 (en) | 2000-06-08 |
AU765977B2 (en) | 2003-10-09 |
TR200200981T2 (tr) | 2002-06-21 |
UY25821A1 (es) | 2001-07-31 |
JP2007077160A (ja) | 2007-03-29 |
DE69907252D1 (de) | 2003-05-28 |
TR200200982T2 (tr) | 2002-06-21 |
JP2002531395A (ja) | 2002-09-24 |
US20040087578A1 (en) | 2004-05-06 |
AR020287A1 (es) | 2002-05-02 |
US20020052367A1 (en) | 2002-05-02 |
EP1131072A2 (en) | 2001-09-12 |
TWI228414B (en) | 2005-03-01 |
KR100421347B1 (ko) | 2004-03-06 |
AU1506500A (en) | 2000-06-19 |
DE69907252T2 (de) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200101470T2 (tr) | Farmasötik bileşim terkipleri. | |
TR200000561T2 (tr) | Amlodipin ve atorvastatin içeren tedavisel bileşikler. | |
BG104075A (en) | Combined treatment including atorvastatin and an antihypertonic form | |
NO20024733D0 (no) | Hydrofile molekyl¶rdisperse lösninger av karvedilol | |
PT951474E (pt) | Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
TR200001542T2 (tr) | Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri. | |
TR200200518T2 (tr) | Felç, Diyabet ve/veya Konjesif Kalp Yetmezliğinin Önlenmesinde Kullanılan Farmolojik Formulasyonlar | |
PT948527E (pt) | Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
MA27311A1 (fr) | Utilisation d'inhibiteurs de cetp et facultativement d'inhibiteurs de hmg-coa-reductase et/ou d'agents antihypertensifs | |
FI953515A0 (fi) | Fluoksetiinin farmaseuttiset formulaatiot | |
DE69908397D1 (de) | Betulinsäure derivate zur behandlung von neuroektodermalen tumoren | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
TR200000562T2 (tr) | Amlodifin ve bir statin bileşiği içeren bileşim terapisi | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
MX9707683A (es) | Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. | |
DE69819539D1 (de) | Antithrombotische mittel | |
IL161116A0 (en) | Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension | |
ATE243515T1 (de) | Verwendung der angiotensin ii-antagonisten losartan und exp-3174 zur behandlung von symptomatisches herzversagen | |
MD554G2 (ro) | Derivaţi noi ai triazolpirimidinelor, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice care le conţin | |
ATE306483T1 (de) | Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung | |
ATE324887T1 (de) | Citalopram zur behandlung von bluthochdruck | |
TR200200111T2 (tr) | Neoplazmalar için terapötik ve profilaktik maddeler | |
UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
ECSP993240A (es) | Preparaciones de combinacion farmaceutica | |
IT1279386B1 (it) | 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizioni |